Cardiovascular medication use after coronary bypass surgery in patients with renal dysfunction: A National Veterans Administration study[1]

• Published in: Kidney international Vol. 68; no. 2; pp. 826 - 832
• Main Authors: Gibney, Eric M., Casebeer, Adrianne W., Schooley, Lynn M., Cunningham, Francesca, Grover, Frederick L., Bell, Missy R., Mcdonald, Gerald O., Shroyer, A. Laurie, Parikh, Chirag R.
• Format: Journal Article
• Language: English
• Published: New York, NY Elsevier Inc 01.08.2005; Nature Publishing
• Subjects: Adrenergic beta-Antagonists - therapeutic use; Aged; Angiotensin-Converting Enzyme Inhibitors - therapeutic use; Biological and medical sciences; cardiac surgery; Cardiology. Vascular system; cardiovascular disease; Cardiovascular Diseases - complications; Cardiovascular Diseases - drug therapy; Cardiovascular Diseases - surgery; Coronary Artery Bypass; Coronary heart disease; Heart; Humans; Hypolipidemic Agents - therapeutic use; Kidney Failure, Chronic - complications; Medical sciences; Middle Aged; mortality; Nephrology. Urinary tract diseases; Nephropathies. Renovascular diseases. Renal failure; Platelet Aggregation Inhibitors - therapeutic use; Postoperative Period; Renal failure; Retrospective Studies; United States; United States Department of Veterans Affairs - statistics & numerical data; United States; mortality; cardiovascular disease; cardiac surgery; Kidney disease; Heart; Human; Nephrology; Urinary system disease; Mortality; Coronary artery; Surgical anastomosis; Cardiovascular disease; Coronary heart disease; Epidemiology; Urology; Treatment; Surgery; Renal failure; Circulatory system; Veteran

Cardiovascular medication use after coronary bypass surgery in patients with renal dysfunction: A national Veterans Administration study. Chronic kidney disease is now recognized as an independent risk factor for cardiovascular events. We sought to determine if cardiovascular medications were utiliz...